Papers and Presentations
How to Search for Resources
You can search for a variety of content on the CASSS website. CASSS makes available any content with author approval. Narrow your search by using the various filters shown below, such as Resource Type, Event Type, and Year. Refine your search as needed.
Refine Results
Filter By Resource Type
Filter By Tags
-
Managing/Leveraging CMOs and CTOs for Lifecycle Success [Session 1]
![System.Collections.Generic.List`1[System.String] Thumbnail](https://www.casss.org/images/default-source/wcbp/2023/wcbp2023_120x120_landing593821b0-7ff0-444d-b8da-38a4481654c2.jpg?sfvrsn=40f36ee0_1)
Roundtable Notes: Session 1 Table 7 WCBP 2025Managing/Leveraging CMOs and CTOs for Lifecycle Success … -
Wide-Spread Adoption of High-Volume Delivery Subcutaneously - What’s the Hold-Up
Roundtable Notes: Session 1 Table 15 WCBP 2025Wide-Spread Adoption of High-Volume Delivery Subcutaneously …
-
What Are the New Alternate Lipids for Lipid Nanoparticles
Roundtable Notes: Session 1 Table 17 WCBP 2025What Are the New Alternate Lipids for Lipid …
-
Vaccine Manufacturing New Technologies for mRNA Production
Roundtable Notes: Session 2 Table 15 WCBP 2025Vaccine Manufacturing New Technologies for mRNA …
-
The Road to One Global CMC Dossier [Session 1]
Roundtable Notes: Session 1 Table 5 WCBP 2025The Road to One Global CMC Dossier [Session 1]
-
The Road to One Global CMC Dossier [Session 2]
Roundtable Notes: Session 2 Table 5 WCBP 2025The Road to One Global CMC Dossier [Session 2]
-
Tech Transfer Challenges and How to Avoid Common Mistakes
Roundtable Notes: Session 2 Table 17 WCBP 2025Tech Transfer Challenges and How to Avoid Common …
-
Setting Specifications on Limited Data, Clinically
Relevant Specs/ Next Generation Control Strategies: Looking Ahead to Revision of ICH
Q6B
Roundtable Notes: Session 1 Table 1 WCBP 2025Setting Specifications on Limited Data, Clinically Relevant …
-
Setting Specification (Including Potency) for Not Well-Characterized Biological Products, e.g., Cell and Gene Therapy Products [Session 2]
Roundtable Notes: Session 2 Table 1 WCBP 2025Setting Specification (Including Potency) for Not Well-Characterized …
-
Relevance of Accelerated and Forced Degradation Studies for a Frozen DS DP [Session 1]
Roundtable Notes: Session 1 Table 6 WCBP 2025Relevance of Accelerated and Forced Degradation Studies …
-
Relevance of Accelerated and Forced Degradation Studies for a Frozen DS DP [Session 2]
Roundtable Notes: Session 2 Table 6 WCBP 2025Relevance of Accelerated and Forced Degradation Studies …
-
Recent Trends in Questions from Global Health Authorities [Session 1]
Roundtable Notes: Session 1 Table 3 WCBP 2025Recent Trends in Questions from Global Health Authorities …
-
Recent Trends in Questions from Global Health Authorities [Session 2]
Roundtable Notes: Session 2 Table 3 WCBP 2025Recent Trends in Questions from Global Health Authorities …
-
Practical Applications of AI and ML in Discovery, Development and Platform Establishment Including CQA Controls
Roundtable Notes: Session 1 Table 13 WCBP 2025Practical Applications of AI and ML in Discovery, Development …
-
Navigating 2-Tier Reference Standard Strategy for Biologics
Roundtable Notes: Session 1 Table 12 WCBP 2025Navigating 2-Tier Reference Standard Strategy for …
-
Moving Away from Animal Testing and Animal Derived Components Including Alternate Endotoxin Test [Session 2]
Roundtable Notes: Session 2 Table 4 WCBP 2025Moving Away from Animal Testing and Animal Derived Components …
-
Moving Away from Animal Testing and Animal Derived Components Including Alternate Endotoxin Test [Session 1]
Roundtable Notes: Session 1 Table 4 WCBP 2025Moving Away from Animal Testing and Animal Derived Components …
-
Microbiological Submission Roadblocks
Roundtable Notes: Session 2 Table 10 WCBP 2025Microbiological Submission Roadblocks
-
Molecule-Independent Device Bridging Approach (MIDBA) – a Novel Proposed Methodology for the Clinical Validation of Subcutaneous Device Platforms
Roundtable Notes: Session 1 Table 16 WCBP 2025Molecule-Independent Device Bridging Approach (MIDBA) …
-
Method Transfer Challenges at CMOs CROs
Roundtable Notes: Session 2 Table 13 WCBP 2025Method Transfer Challenges at CMOs CROs